On (b)(6) 2023 apifix was notified that eos patient (b)(6) is scheduled for implant removal on (b)(6) 2023 and conversion to fusion.No allegation of deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance of an apifix device was received.
|
A review of the device history record confirmed that the device was manufactured and tested according to relevant procedures, and shipped according to manufacturer's specifications.(eos) patient (b)(6) index procedure was performed on (b)(6)2022.On (b)(6) 2023 apifix was notified that eos patient (b)(6) is scheduled for implant removal on (b)(6) 2023 and conversion to fusion.No allegation of deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance of an apifix device was received.Device will not be returned to the manufacturer. the patient wants to keep it.(it's his property by law.) and because it was a planned removal without any implant issues, the clinic agreed. although no allegation of deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance of an apifix device was received, this event involved a removal surgery.Apifix believes that subjecting a patient to another round of anesthesia and additional surgery carries inherent risks, and in an abundance of caution, apifix is reporting this as an adverse event.Apifix is closing this complaint, but will continue to monitor this 'failure mode'; complaint trending will continue to monitor per post marketing surveillance procedure.If any further relevant information is identified, the complaint file will be reopened and a supplemental medwatch will be filed.
|